Shenyang Xingqi Pharmaceutical Co.,Ltd

SZSE:300573.SZ

150.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12014 Q4
Revenue 536.141504.095539.611534.09345.82358.854419.393398.91286.56245.583403.7298.614301.959257.568307.982255.165207.2219.334232.541154.09782.71132.368158.699140.381110.98694.233134.869113.18288.92178.78698.4496.08786.69479.54694.13686.82378.59562.237
Cost of Revenue 106.395109.977116.403120.25183.61392.61485.62993.20568.86570.49478.45461.36359.76759.08760.5557.86947.7454.42959.47244.83126.29736.13439.47740.50428.93522.68634.88633.428.38723.78625.61725.82118.71718.99420.78820.9923.33519.091
Gross Profit 429.746394.118423.208413.838262.206266.241333.764305.705217.696175.089325.246237.251242.192198.481247.433197.295159.46164.905173.069109.26656.41396.234119.22399.87782.05171.54699.98479.78260.53455.00172.82270.26667.97660.55273.34865.83355.2643.147
Gross Profit Ratio 0.8020.7820.7840.7750.7580.7420.7960.7660.760.7130.8060.7950.8020.7710.8030.7730.770.7520.7440.7090.6820.7270.7510.7110.7390.7590.7410.7050.6810.6980.740.7310.7840.7610.7790.7580.7030.693
Reseach & Development Expenses 47.07278.15460.78240.63338.06843.19643.84149.02628.68455.16739.84928.28722.31226.1823.99318.24920.02514.90416.58818.59713.10413.08216.45914.559.87613.2689.11611.2538.6328.49411.38812.674019.58606.21800
General & Administrative Expenses 0-47.48985.798-6.48138.7-52.97784.359-1.92330.09411.365101.626-16.01834.98-46.72168.829-8.62725.675-27.6721.71-8.51919.203-29.7518.921-8.94617.111-22.35112.638-11.27120.721-36.65122.289-10.41817.555-25.87417.895-9.23614.564-21.109
Selling & Marketing Expenses 0-132.519339.898181.369150.011124.75138.779137.812133.966120.718140.63106.83395.25388.07696.75785.09268.34681.0880.98447.84534.30549.30156.1262.29751.56443.156.95753.01140.33134.55632.94129.50636.82832.65539.62230.98928.30132.136
SG&A 205.375-180.009226.742174.888187.522160.384223.138135.89164.06129.112242.25690.815130.23241.355165.58676.46594.02153.409102.69439.32753.50919.55175.04153.35268.67520.74869.59541.7461.052-2.09455.2319.08754.3836.78157.51721.75342.86511.027
Other Expenses -0.847420.51-1.358-261.1271.761-5.541-0.903-7.233-2.4090-55.86653.6462.7822.574-3.791-3.317-0.322-0.671-1.004-0.517-1.004-0.845-0.043-1.040.057-1.3710.526.399-7.11-0.283-0.258-0.5210.7183.2750.3756.870.47517.844
Operating Expenses 251.6321.677287.52261.127223.83209.122224.612228.203190.334180.961226.239172.747155.326147.686155.788133.023116.171119.803120.71980.81766.33386.04591.47893.17379.76771.54781.07979.39262.57557.12956.1545.12256.75752.25259.13240.88544.17445.633
Operating Income 178.14672.441134.325152.71138.37757.118110.53378.41722.867-15.28499.39365.24387.95948.43897.32860.9241.71241.53447.68626.83-10.3136.35425.6694.4151.25-0.67615.904-0.595-3.108-3.39915.75624.3819.4087.59815.09122.268.542-5.453
Operating Income Ratio 0.3320.1440.2490.2860.1110.1590.2640.1970.08-0.0620.2460.2180.2910.1880.3160.2390.2010.1890.2050.174-0.1250.0480.1620.0310.011-0.0070.118-0.005-0.035-0.0430.160.2540.1090.0960.160.2560.109-0.088
Total Other Income Expenses Net -0.612-15.2693.209-2.8183.2795.183-0.903-7.233-0.98911.538-0.679-12.248-2.2032.5742.5-4.709-2.635-0.671-2.85-0.517-1.0041.972-1.473-2.062-0.978-1.371-2.5010.0070-0.153-1.1740.05703.3310.3756.87-2.07117.751
Income Before Tax 177.53457.172137.534158.66941.65662.302109.6371.18421.878-3.74698.71452.99585.75651.01293.53757.60341.3940.86346.68226.314-11.3175.50925.6273.3741.306-2.04716.404-0.08-3.108-3.55215.49823.76310.12610.87215.46629.1299.01512.298
Income Before Tax Ratio 0.3310.1130.2550.2970.120.1740.2610.1780.076-0.0150.2450.1770.2840.1980.3040.2260.20.1860.2010.171-0.1370.0420.1610.0240.012-0.0220.122-0.001-0.035-0.0450.1570.2470.1170.1370.1640.3360.1150.198
Income Tax Expense 31.6399.87316.09224.0986.9074.59715.0532.7792.52812.59216.5096.5311.58711.15712.2667.1653.8462.4645.620.3520.6450.0854.4650.351.406-0.6752.632-1.742-1.617-0.1312.3233.6041.6011.972.1324.5691.5331.779
Net Income 145.89547.299121.442134.57134.74957.70594.57768.40519.3498.84682.20546.46474.16938.62875.93646.93233.20634.24438.4225.75-10.4357.34322.8254.6631.0620.46215.0790.677-2.559-2.42113.17520.1588.5258.90213.33524.5617.48210.519
Net Income Ratio 0.2720.0940.2250.2520.10.1610.2260.1710.0680.0360.2040.1560.2460.150.2470.1840.160.1560.1650.167-0.1260.0550.1440.0330.010.0050.1120.006-0.029-0.0310.1340.210.0980.1120.1420.2830.0950.169
EPS 0.830.270.70.770.280.460.760.550.160.0520.930.530.840.450.910.570.40.420.470.32-0.130.090.280.0440.010.0010.020.008-0.03-0.030.160.260.110.150.220.390.120.17
EPS Diluted 0.830.270.70.770.280.460.760.550.160.0520.930.530.840.450.910.570.40.420.470.32-0.130.090.280.0440.010.0010.020.008-0.03-0.0290.160.260.110.150.220.390.120.17
EBITDA 179.03485.274139.339186.65358.7386.617133.79693.20643.8721.224118.33773.721106.81871.39113.9476.82360.53855.03959.67238.81.42217.7136.0615.09611.245-1.29719.380.421-1.607-3.7116.92424.312.13517.61424.13831.19111.08613.11
EBITDA Ratio 0.3340.1690.2580.3490.170.2410.3190.2340.1530.0050.2930.2470.3540.2770.370.3010.2920.2510.2570.2520.0170.1340.2270.1080.101-0.0140.1440.004-0.018-0.0470.1720.2530.140.2210.2560.3590.1410.211